Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.43
-0.05 (-3.38%)
At close: Aug 15, 2025, 3:59 PM
1.47
3.14%
After-hours: Aug 15, 2025, 07:58 PM EDT
Galmed Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.58 | -0.4 | -0.06 | -0.4 | -4.06 | -3.3 | -7.89 | -9.46 | -19.44 | -13.36 | -4.37 | -13.11 | -19.31 | -18.37 | -27.2 | -27.23 | -27 |
PEG Ratio | 0.01 | -0.01 | -0.00 | -0.00 | 0.10 | -0.05 | 0.11 | 2.34 | 0.47 | 0.28 | -0.1 | 0.33 | 1.13 | 5.65 | 3.33 | 2.25 | 1.34 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.15 | 0.31 | 0.03 | 0.15 | 1.62 | 1.92 | 2.99 | 5.71 | 10.75 | 11.26 | 5.97 | 9.44 | 19.64 | 17.96 | 22.28 | 20.33 | 18.16 |
P/FCF Ratio | -2.2 | -2.6 | -0.45 | -1.75 | -11.31 | -29.67 | -21.35 | -44.1 | -76.06 | -37.55 | -30.18 | -33.07 | -87.76 | -78.34 | -93.4 | -119.74 | -103.54 |
P/OCF Ratio | -2.2 | -2.6 | -0.45 | -1.75 | -11.31 | -29.67 | -21.35 | -44.1 | -76.06 | -37.56 | -30.18 | -33.09 | -87.76 | -78.35 | -93.42 | -119.85 | -103.55 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 9.02 | 7.42 | 7.03 | 6.48 | 6.55 | 4.81 | 7.65 | 3.55 | 4.54 | 4.72 | 4.07 | 8.48 | 5.26 | 6.13 | 6.88 | 7.37 | 8.37 |
Current Ratio | 9.02 | 7.42 | 7.03 | 6.48 | 6.34 | 4.81 | 6.79 | 3.59 | 4.58 | 4.76 | 4.07 | 8.48 | 5.26 | 6.13 | 6.88 | 7.37 | 8.37 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | -293.6 | n/a | n/a | -12.89 | -179.33 | -932.5 | -119.45 | -173.3 | n/a | n/a | n/a |
Return on Equity | -0.07 | -0.2 | -0.1 | -0.09 | -0.1 | -0.15 | -0.09 | -0.15 | -0.14 | -0.21 | -0.34 | -0.18 | -0.25 | -0.24 | -0.2 | -0.19 | -0.17 |
Return on Assets | -0.06 | -0.17 | -0.09 | -0.08 | -0.09 | -0.12 | -0.08 | -0.12 | -0.11 | -0.17 | -0.26 | -0.16 | -0.21 | -0.2 | -0.17 | -0.16 | -0.15 |
Return on Invested Capital | -0.07 | -0.1 | -0.11 | -0.1 | -0.11 | -0.15 | -0.09 | -0.18 | -0.15 | -0.19 | -0.34 | -0.18 | -0.25 | -0.24 | -0.21 | -0.19 | -0.17 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |